AAAAX | CIBFX | AAAAX / CIBFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 24 years | - |
Gain YTD | 3.431 | 5.075 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.18B | 110B | 4% |
Annual Yield % from dividends | 2.04 | 3.22 | 63% |
Returns for 1 year | 10.90 | 12.07 | 90% |
Returns for 3 years | 3.97 | 13.67 | 29% |
Returns for 5 years | 25.37 | 27.53 | 92% |
Returns for 10 years | 56.24 | 35.38 | 159% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 132.46 | -0.77 | -0.58% |
Franklin Biotechnology Discovery R6 | |||
LOGBX | 36.38 | -0.28 | -0.76% |
Scharf Multi-Asset Opportunity Retail | |||
KCVSX | 17.41 | -0.24 | -1.36% |
Knights of Columbus Large Cap Value S | |||
MLGRX | 7.93 | -0.19 | -2.34% |
NYLI Winslow Large Cap Growth Class R3 | |||
MBCYX | 23.06 | -0.56 | -2.37% |
MassMutual Blue Chip Growth Svc |